TP53 and breast carcinoma: These RNAs constitute a network that regulates the epithelial–mesenchymal transition (EMT) with p53, promoting an epithelial gene expression program in breast cancer, e.g., through the targeting of ZEB1/2 EMT transcription factors [23].